• Photo: Close-up of human eye

    Restore Vision 20/20: Announcing our biggest research initiative ever!
    This year, the Foundation Fighting Blindness is launching the Restore Vision 20/20 initiative: a bold and ambitious plan to support researchers who are ready to transform their discoveries into sight-restorative therapies.
    Learn more

  • Photo: Salvina and her brother

    Rallying Together To Treat Retinitis Pigmentosa (RP): Salvina’s Story
    Five-year-old Salvina lives with reitinitis pigmentosa. Instead of taking her diagnosis lying down, her family decided to do something. Since then they've raised thousands of dollars to accelerate blindness research and bring us closer to treatments and cures.
    Read Salvina's Story

  • Photo: Barbara Milner

    Barbara Embodies the Fight Against Blindness
    Barbara Milner is both deaf and blind. At 58 years old, she has lived her entire life with a condition called Usher syndrome—a rare genetic disorder that leads to acute hearing and vision loss. Those who live with the disease must often confront isolation, loneliness, and profound social barriers. Barbara has confronted these challenges with boundless vigour and determination, leaving those around her inspired.
    Read Barbara's story

  • Photo: Dr. Robert Molday

    Power In Partnerships
    Gene therapy pioneer, Dr. Robert Molday, highlights the FFB's 30-year relationship with the University of British Columbia.
    Watch the video

  • Molly Burke

    Hope & Healing: Molly Burke's Inspiring Journey
    Over one million Canadians are living with retinal eye diseases. Read Molly’s story and join us to restore hope and sight.
    Read the full story

The Foundation Fighting Blindness leads the fight against blindness by advancing retinal disease research, education and public awareness.

FFB News

Gene Therapy Improves Vision in Landmark Clinical Trial

July 14th, 2017 by Dr. Mary Sunderland

Yesterday, a landmark publication in The Lancet, a prestigious journal, showed that gene therapy can improve vision in people living with a rare blinding eye disease. The study examined the effects of an experimental gene therapy – voretigene neparvovec – to treat an inherited blinding eye disease caused by mutations in the RPE65 gene. RPE65…

Read More

header

Top 10 Science-y Summer Tips

June 29th, 2017 by FFB Canada

So far this year, the pace of vision research has been sizzling! To celebrate the arrival of sizzling weather, we asked the Foundation Fighting Blindness (FFB) staff to share their favourite FFB science stories from the archives. Kick back, relax, and enjoy our top 10 list of vision health tips, science stories, and sight-saving science…

Read More

Photo: Facebook Live Logo with laboratory faded in background

Let’s Talk Gene Therapy Research With Dr. Mary Sunderland & Dr. Chad Andrews (VIDEO)

June 12th, 2017 by FFB Canada

On the first Tuesday of every month, the Foundation Fighting Blindness sends out our e-newsletter featuring the latest and most exciting research breakthroughs. Soon after each e-newsletter, our very own Director of Research and Education, Dr. Mary Sunderland, takes to our Facebook page to do a live broadcast discussion of the articles featured in the…

Read More

Illustration: DNA Strand over DNA letters

Clinical Trial Updates: Gene Therapy

June 6th, 2017 by FFB Canada

Many experts agree that gene replacement therapy is a novel approach to treating inherited degenerative retinal diseases, especially when the disease is caused by a single gene defect (or mutation). Gene replacement therapies are sometimes described as “gene addition” or “gene augmentation” therapies because the treatment strategy involves replacing a damaged gene with a new,…

Read More

Research and foundation news straight to your inbox.

Sign Up

Enter your email address to receive updates

All fields marked with an asterisk (*) are required

First Name *
Last Name *
Your Email *

Subscribe me to FFB E-News